Vasculitis & polymyalgia rheumatica

High risk of stroke in ANCA-associated vasculitis—a population-based study

Rheumatology (Oxford)Published Population-based cohort study

Main finding · Stroke incidence rate (per 1000 person-years)Result — go to the resultStandardized incidence ratio 1.85 95% CI 1.27–2.59

Authors' conclusion

The incidence rate of stroke in AAV is higher than in the general population. High platelet count at AAV diagnosis was associated with an increased risk of stroke.

Study context

Population
Patients diagnosed with ANCA-associated vasculitis (AAV) 1997–2016 in a defined geographic area of Sweden (Skåne)
Participants
325 patients2,206 person-years
Exposure
AAV vs Swedish general population
  • AAVn = 325
Outcome
Incidence rate of stroke per 1000 person-years
Methodological detailsStandardized incidence ratio (SIR) vs Swedish general population, Cox regression
  • SIR vs Swedish general population
  • Cox regression

Main finding

Stroke incidence rate (per 1000 person-years)

Standardized incidence ratio

1.85

95% CI 1.27–2.59

By group

AAV

11.3

95% CI 6.9–15.8 · /1000 person-years

AAVvs General population
SIR 1.85 (95% CI 1.27–2.59)

As reported in the abstract

Stroke during 2206 person-years of follow-up
25 (8%)

Observational data: associations, not effects.

Further findings

OutcomeSIR (95% CI)
Stroke in those <65 years (subgroup)3.19 (1.53–5.88)

Predictor of stroke: higher platelet count at AAV diagnosis

HR (95% CI)
Higher platelet countIndependent predictor1.14 (1.00–1.29)

Survival and other outcomes, AAV with vs without stroke

No differences in survival or other outcome measures between AAV patients with and without stroke

Original publication

High risk of stroke in ANCA-associated vasculitis—a population-based study. Rheumatology (Oxford). Published 28 November 2022. doi:10.1093/rheumatology/keac669

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.